Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 31, 2026, titled “Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH”|SUBJECT: Press Release
Source link